The specialized oncology therapeutics sector is experiencing unprecedented growth, particularly in niche markets addressing rare and aggressive cancers. The Malignant Fibrous Histiocytoma Market exemplifies this trend, representing a high-value therapeutic area where innovative treatments can significantly impact patient outcomes while generating substantial commercial returns for...